rubitecan: Clinical Trials

3 trials of rubitecan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow rubitecan: new trials by email Literature Review of rubitecan trials Research Report on rubitecan

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
Temozolomide, L9-NC - Ewing's Sarcoma
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center102006-06-012012-08-02
Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Rubitecan - Tumors
Phase 1CompletedAstex Pharmaceuticals, Inc.542001-08-012024-08-02
Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide
Oral Etoposide, Oral 9-Nitrocamptothecin - Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute442000-06-012012-09-26

Conditions studied

Liver Diseases (1)  ·  Neoplasms (1)  ·  Renal Insufficiency (1)  ·  Sarcoma, Ewing (1)

Sponsors

Astex Pharmaceuticals, Inc. (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (3)

Top investigators

Cynthia E. Herzog, MD (1)  ·  Daniel M. Sullivan, M.D. (1)